Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial (Q33429869)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial |
scientific article |
Statements
1 reference
Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial (English)
1 reference
Jifang Gong
1 reference
Tianshu Liu
1 reference
Qingxia Fan
1 reference
Li Bai
1 reference
Feng Bi
1 reference
Shukui Qin
1 reference
Jinwan Wang
1 reference
Nong Xu
1 reference
Ying Cheng
1 reference
Yuxian Bai
1 reference
Wei Liu
1 reference
Liwei Wang
1 reference
Lin Shen
1 reference
1 January 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference